Clinical Trials Logo

Chronic Obstructive clinical trials

View clinical trials related to Chronic Obstructive.

Filter by:
  • None
  • Page 1

NCT ID: NCT03518723 Recruiting - Pulmonary Disease Clinical Trials

Effect and Feasibility of Non-linear Periodized Resistance Training in People With COPD

Start date: April 16, 2018
Phase: N/A
Study type: Interventional

This study aims at improving the knowledge about resistance training for people with COPD. Resistance training is an important part of pulmonary rehabilitation when the goal is to improve muscular endurance and strength. The study will evaluate the effects and the feasibility of two resistance training programs for people with COPD using a parallel group design. One program will include a larger day-to-day variation (i.e. non-linear periodization) and the progression will be guided by ratings of dyspnea, muscle fatigue, and exertion. The other program will follow the established guidelines for resistance training for people with COPD. The programs will be evaluated for effects regarding muscular endurance, strength, intramuscular adaptions, functional preformance, dyspnea, and health related quality of life. The programs will also be evaluated for feasibility regarding the duration of training sessions, attendance rates, adverse events, and participant satisfaction. The hypothesis is that the non-linear periodization group will have superior effects and that feasibility aspects will be similar between groups.

NCT ID: NCT02446041 Completed - Pulmonary Disease Clinical Trials

ICS/LABA Adherence and COPD Exacerbation

Start date: May 2015
Phase: N/A
Study type: Observational

The purpose of this retrospective, non-interventional sutdy is to compare the effectiveness of ICS/LABA combination therapy in the reduction of COPD exacerbations during the 12 months after initiation of therapy between COPD patients who are adherent to the index medication and those who are non-adherent.

NCT ID: NCT00888342 Completed - Pulmonary Disease Clinical Trials

Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in COPD Patients

Start date: May 2009
Phase: N/A
Study type: Interventional

Respiration failure type 2 is loss of the lungs ability to take up oxygen (O2) and get rid of carbon dioxide (CO2). The diagnosis is based on blood gas measurement of pressures of O2 and CO2. Patients with COPD is often seen to have co-morbidity with cardiac diseases. Chronic systemic inflammation is seen in both COPD and cardiac diseases. The investigators will investigate the sleep quality, CO2-retention, O2-saturation, cardiac arrythmias and markers of inflammation in 120 patients with COPD in different stages of the disease. Our hypotheses are: - that the first signs of respiration failure type 2 is seen during sleep with alteration of sleep patterns and greater and more long-lasting retention of CO2 in the blood compared to those with a normal lung function - that the use of alcohol, zopiclone or supplementary oxygen will make these differences even greater - that cardiac arrythmias correlates with hypoxemia - that cardiac arrythmias and respiration failure correlates with degree of inflammation

NCT ID: NCT00851695 Completed - Asthma Clinical Trials

Examining the Role of Vitamin D in Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Start date: July 2007
Phase: N/A
Study type: Observational

Asthma and chronic obstructive pulmonary disease (COPD) are diseases that affect a person's ability to breathe normally. People who do not receive enough vitamin D may have a higher risk of developing asthma or COPD. This study will examine previously collected blood samples of participants in three studies to determine whether people with low vitamin D levels have an increased risk of severe asthma or COPD.